A Pilot, Randomized, Double-blind, Placebo-controlled Single-center Study to Evaluate the Safety and Efficacy of SUBSYS (Fentanyl Sublingual Spray) for the Treatment of Acute Procedure-related Pain in a Monitored Setting
Status: Withdrawn prior to enrolment
Phase of Trial: Phase III
Latest Information Update: 29 Dec 2017
Price : $35 *
At a glance
- Drugs Fentanyl (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use
- Sponsors INSYS Therapeutics, Inc
- 21 Dec 2017 Status changed from not yet recruiting to withdrawn prior to enrolment.
- 01 Dec 2017 Planned End Date changed from 1 Dec 2017 to 1 Jan 2018.
- 01 Dec 2017 Planned primary completion date changed from 1 Dec 2017 to 1 Jan 2018.